Navigation Links
Kuros Completes Patient Recruitment in a Phase IIb Clinical Trial With KUR-211 for Diabetic Foot Ulcers
Date:8/31/2011

ZURICH, Switzerland, September 1, 2011 /PRNewswire/ --

Study Assessing the Safety and Efficacy of KUR-211 Expected to Report in mid 2012

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has completed recruitment in a Phase IIb clinical trial designed to investigate KUR-211 (Viz.I-020201) in the treatment of diabetic foot ulcers.

This Phase IIb clinical trial is a randomised, multi-center, controlled, parallel group dose-finding study to evaluate the efficacy and safety of KUR-211 used as an adjunct to standard of care in patients with diabetic foot ulcers. KUR-211 is a bioactive therapy intended for topical treatment of diabetic foot ulcers, stimulating the granulation tissue formation, that aids wound closure. The study evaluates the effects of KUR-211 applied twice a week for maximum 16 weeks in addition to standard of care versus standard of care (SOC) alone.

KUR-211 consists of a modified variant of platelet-derived growth factor (PDGF) incorporated into a fibrin sealant and is applied to the wound as a foam. The innovative Kuros "TG-hook" technology enables the PDGF to be retained at the site for local exposure to migrating cells and for sustained delivery of PDGF on enzymatic cleavage of the matrix. It is believed that this novel approach may improve the frequency and speed of healing.

A total of 211 patients have been randomized and treated in over 27 centers across Europe including Russia. The primary endpoint of this study is percentage reduction in ulcer surface area after 4 weeks of treatment when compared to SOC alone.  Patients are followed for 7 months following initial treatment. Kuros is expecting to report the outcome of this study around the middle of 2012.

Dr. Virginia Jamieson, Chief Medical Officer of Kuros, commented: "We are very pleased t
'/>"/>

SOURCE Kuros Biosurgery AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kuros Announces Allowance of European Patent for Synthetic Biomaterials
2. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
3. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
4. Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
5. Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol
6. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
7. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
8. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
9. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
10. Roche completes acquisition of ARIUS
11. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Hayden-McNeil is pleased to announce they ... for smaller courses. This program is specifically designed for ... , “I’m very excited about offering our publishing ... said Jeff McCarthy, Hayden-McNeil president. “By working with more ... to make education both more effective and affordable.” , ...
(Date:5/5/2015)... AVIV, Israel , May 5, 2015 /PRNewswire/ ... the Company was approved to continue trading on ... OTCQB Marketplace allows for a ... electronic broker-dealers. Investors can have real-time quotes and ... The OTCQB Marketplace includes U.S. ...
(Date:5/5/2015)... 5, 2015 Reprints Desk, Inc., a Research ... access to scientific, technical and medical (STM) content, today ... Association of Southeastern Research Libraries (ASERL) . ... across 11 southeastern states. Founded in 1956, ASERL has ... to address the continually changing needs of its member ...
(Date:5/5/2015)... USA (PRWEB) May 05, 2015 A ... covering a wide range of key photonics technologies – ... global competitiveness of U.S. industry. To help the community ... on 12 May on the proposed changes to ... commodities covered by International Traffic in Arms Regulations (ITAR). ...
Breaking Biology Technology:Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2Association of Southeastern Research Libraries Partners with Reprints Desk to Improve Access for Hard-to-Find Materials 2Association of Southeastern Research Libraries Partners with Reprints Desk to Improve Access for Hard-to-Find Materials 3Association of Southeastern Research Libraries Partners with Reprints Desk to Improve Access for Hard-to-Find Materials 4Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4
... 29 Nastech,Pharmaceutical Company Inc. (Nasdaq: NSTK ... nine-month periods ended September 30, 2007. Revenue ... $1.9 million,compared to $5.5 million for the quarter ... of $4.8 million related to our Parathyroid Hormone,(PTH1-34) ...
... Oct. 29 /PRNewswire/ - N30 Pharma (N30), a,biopharmaceutical ... respiratory drugs that target endogenous,s-nitrosothiols, today announced a ... covering the respiratory use of a s-nitrosothiol drug,candidate. ... "I am extremely pleased to announce this ...
... LA JOLLA, Calif., Oct. 29 TorreyPines Therapeutics,Inc. (Nasdaq: ... President and,Chief Executive Officer of TorreyPines, will present at ... in New York on Monday,November 5th at 9:10 a.m., ... be available live. You can,access the webcast at: ...
Cached Biology Technology:Nastech Announces Third Quarter 2007 Financial Results 2Nastech Announces Third Quarter 2007 Financial Results 3Nastech Announces Third Quarter 2007 Financial Results 4Nastech Announces Third Quarter 2007 Financial Results 5Nastech Announces Third Quarter 2007 Financial Results 6
(Date:3/31/2015)...  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ("Elephant ... Defined Network Architecture (ET Software DNA® 2.0) platforms and ... $20.4 million for the year ended December 31, 2014 ... year ended December 31, 2013. At ... its multi-year transition away from its legacy landline business ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... the "Global Gesture Recognition Market in Automotive Sector ... analysts forecast the Global Gesture Recognition market in Automotive ... the period 2013-2018. Gesture recognition is the ... different gestures of an individual. Gesture recognition technology can ...
(Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... grains with solubles (DDGS) to growing pigs, many questions are ... "Previous research shows that while the amount of energy ... lower digestibility of energy in DDGS than in corn," said ... Department of Animal Sciences. "Our goal was to find out ...
... University of Pennsylvania biologists studying human reproduction ... factor to the maternal age-associated increase in aneuploidy, ... during reproductive cell division. Using naturally aging ... of reproductive life is most likely caused by ...
... who develop life-threatening bacterial infections, or septicemia, with insulin ... infection, if results of a new preliminary study can ... online ahead of print in Diabetes Care ... oxidative stress in study participants who had been injected ...
Cached Biology News:Swine researchers seek answers to fiber's low digestibility 2Why the biological clock? Penn study says aging reduces centromere cohesion, disrupts reproduction 2Insulin may reduce several inflammatory factors induced by bacterial infection 2
... Introduction of a protein into cells permits ... signaling pathways, apoptotic pathways, and transcription factor-mediated ... studying the effects of a specific protein ... the protein directly into the cell. ProteoJuice ...
... SE flow cytometry system is the superior ... over 25 years, BD cell sorters have ... in leading university, pharmaceutical, and biotechnology research ... the research demands of today, we have ...
... is a microarray service provider ... academic researchers. We are a ... and we provide expression profiling ... arrays. Gene expression reports ...
... Control and regulate cell stretching or compression ... microscope stage. Computer controlled so you can ... the strain to produce 64 unique strain ... then the ST-150. Both models are compatible ...
Biology Products: